Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
500660
Company
GLAXOSMITHKLINE PHARMACEUTICALS LTD.
Exchange Received Time
24/05/2018 18:44:14
Exchange Disseminated Time
24/05/2018 18:44:20
Time Taken
00:00:06
Corporate Action-Board approves Dividend |
5/24/2018 6:44:15 PM
we are pleased to furnish the following information:
1. Dividend
The Board has recommended a dividend of Rs. 35/- per equity share on face value of Rs. 10 each for the year ended 31st March 2018. The dividend if approved by the shareholders will be paid after 24th July 2018.
2. Intimation under Listing and Disclosure Requirements Regulations, 2015 (LODR) Pursuant to the Regulation 33 of LODR the following documents are enclosed as Annexure 1 & 2
Audited Financial Results for the year ended 31st March 2018
Auditors Report for the year ended 31st March 2018
Audited Financial Results for quarter ended 31st March 2018
Statement of Assets and Liabilities
Certificate for unmodified opinion
3. Annual General Meeting
The Ninety Third Annual General Meeting of the Company will be held on Tuesday, 24th July 2018 at the Birla Matushri Sabhagar, 19, Marine Lines, Mumbai 400020.
Attachment
<< Back
Recently Viewed